Oct. 13, 2008 – Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, announced that it has acquired the EndoTool® business from MD Scientific, LLC. The EndoTool glucose management system, a highly sophisticated software system cleared by the U.S. Food and Drug Administration (FDA), helps establish and maintain glycemic control in acute, critical care and operating room settings by calculating the dose of intravenous (I.V.) insulin needed to effectively control blood glucose levels... Hospira's Press Release -
Thursday, October 16, 2008
Hospira : EndoTool from MD Scientific
Oct. 13, 2008 – Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, announced that it has acquired the EndoTool® business from MD Scientific, LLC. The EndoTool glucose management system, a highly sophisticated software system cleared by the U.S. Food and Drug Administration (FDA), helps establish and maintain glycemic control in acute, critical care and operating room settings by calculating the dose of intravenous (I.V.) insulin needed to effectively control blood glucose levels... Hospira's Press Release -
